Maryland State Retirement & Pension System Has $213,000 Stock Position in Bruker Corporation $BRKR

Maryland State Retirement & Pension System lowered its position in Bruker Corporation (NASDAQ:BRKR) by 14.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,102 shares of the medical research company’s stock after selling 881 shares during the period. Maryland State Retirement & Pension System’s holdings in Bruker were worth $213,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Teacher Retirement System of Texas boosted its position in shares of Bruker by 5.1% during the first quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company’s stock valued at $1,212,000 after buying an additional 1,422 shares during the last quarter. Fifth Third Bancorp lifted its stake in Bruker by 54.2% during the 1st quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company’s stock valued at $46,000 after acquiring an additional 390 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in Bruker by 81.2% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company’s stock worth $1,245,000 after acquiring an additional 13,367 shares during the last quarter. OneDigital Investment Advisors LLC grew its stake in shares of Bruker by 38.0% in the 1st quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company’s stock worth $230,000 after acquiring an additional 1,520 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in shares of Bruker by 45.8% in the 1st quarter. UMB Bank n.a. now owns 1,325 shares of the medical research company’s stock worth $55,000 after acquiring an additional 416 shares in the last quarter. Institutional investors own 79.52% of the company’s stock.

Bruker Stock Up 1.8%

Shares of NASDAQ:BRKR opened at $34.84 on Wednesday. Bruker Corporation has a one year low of $30.00 and a one year high of $72.94. The firm has a fifty day moving average price of $38.78 and a two-hundred day moving average price of $41.40. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.61 and a quick ratio of 0.70. The company has a market cap of $5.29 billion, a price-to-earnings ratio of 67.00, a PEG ratio of 2.83 and a beta of 1.16.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.33 by ($0.01). The company had revenue of $797.40 million for the quarter, compared to analysts’ expectations of $811.17 million. Bruker had a net margin of 2.31% and a return on equity of 17.89%. The business’s quarterly revenue was down .4% compared to the same quarter last year. During the same quarter last year, the business posted $0.52 EPS. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Analysts anticipate that Bruker Corporation will post 2.69 EPS for the current fiscal year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 3rd. Investors of record on Tuesday, September 23rd will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, September 23rd. Bruker’s dividend payout ratio (DPR) is presently 38.46%.

Analysts Set New Price Targets

Several research analysts recently weighed in on BRKR shares. The Goldman Sachs Group cut their price target on shares of Bruker from $50.00 to $45.00 and set a “neutral” rating on the stock in a report on Thursday, May 8th. Wells Fargo & Company cut their target price on Bruker from $60.00 to $50.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 5th. Bank of America reduced their target price on Bruker from $61.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, June 26th. Stifel Nicolaus set a $40.00 price target on Bruker and gave the stock a “hold” rating in a report on Tuesday, August 5th. Finally, UBS Group cut their price objective on Bruker from $57.00 to $45.00 and set a “neutral” rating on the stock in a research report on Thursday, May 8th. Five analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $51.30.

Insider Activity at Bruker

In related news, CEO Frank H. Laukien bought 2,608 shares of the business’s stock in a transaction dated Friday, June 6th. The shares were purchased at an average price of $38.36 per share, with a total value of $100,042.88. Following the transaction, the chief executive officer owned 38,462,171 shares in the company, valued at $1,475,408,879.56. This trade represents a 0.01% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 27.30% of the stock is owned by insiders.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.